XLXiaoling Liu

Xiaoling Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaoling Liu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Fanding He

    Department of Medical Ultrasound, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China

    1 shared publication
  • Jing Qiao

    Department of Ultrasound, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China

    1 shared publication
  • Qi Luo

    Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China

    1 shared publication
  • Weihan Xiao

    North Sichuan Medical College, Nanchong 637000 China

    1 shared publication
  • Xia Han

    Department of Obstetrics and Gynecology, Shenzhen Hospital of Guangzhou University of Chinese Medicine (Futian), Shenzhen, Guangdong, China

    1 shared publication
  • Xiachuan Qin

    Department of Ultrasound, West China School of Medicine, Sichuan University, Sichuan University affiliated Chengdu Second People’s Hospital, Chengdu Second People’s Hospital, Chengdu, China

    1 shared publication

Latest Publications

  • Prediction of Lymph Node Metastasis in Endometrial Cancer Based on Color Doppler Ultrasound Radiomics

    by Xiaoling Liu, Weihan Xiao, Jing Qiao, Qi Luo, Xiang Gao, Fanding He, Xiachuan Qin


  • Open Access

    FANCI may serve as a prognostic biomarker for cervical cancer

    by Xiaoling Liu, Xiqin Liu, Xia Han

    Background: DNA damage is a fundamental process that plays a considerable role in generating protein diversity. FANCI, loaded on the altered chromatin, plays a vital role in DNA damage. Abnormal FANCI expression is potentially associated with carcinogenesis.However, the biological role of FANCI in cervical cancer is yet to be determined. Methods: We analyzed FANCI expression via multiple gene expression databases. Genes co-expressed with FANCI and its regulators were identified using LinkedOmics. The correlations between FANCI and cancer immune infiltrates were investigated via Tumor Immune Estimation Resource (TIMER). Results: FANCI was found upregulated with amplification in tumor tissues of multiple cervical cancer cohorts. High FANCI expression was associated with poorer overall survival (OS). Functional network analysis suggested that FANCI regulates spliceosome, DNA replication, and cell cycle signaling via pathways involving several cancer-related kinases and the E2F family. In additional, FANCI expression was positively correlated with infiltrating levels of CD4+ T and CD8+ T cells, and neutrophils. FANCI expression also showed strong correlations with diverse immune marker sets in cervical cancer. Conclusion: These findings suggested that FANCI is correlated with prognosis of and immune infiltration in cervical cancer, laying a foundation for further study of the immune regulatory role of FANCI in cervical cancer.